New Report Provides 2014-2022 Overview of Global HIV Diagnostics Market
New Market Research Reports Title "HIV Diagnostics Market 2018" Has Been Added to Crystal Market Research Report database.
HIV Diagnostics - Competitive Outlook and Trend Analysis
Major market players of the HIV diagnostics market are Abbott Healthcare, Abbvie Inc., Alere Inc., Bristol-Myers Squibb, Gilead Sciences, Janssen Therapeutics, Merck & Co. Inc, BD Biosciences, VIIV Healthcare, Partec, Beckman Coulter, bioMerieux, Apogee Flow Systems, Zyomyx Inc., PointCare Technologies Inc., Mylan Unc., Qiagen, Roche Diagnostics, Siemens Healthcare, and Sysmex. These key players in the global market are involved in the research and development of p24 antigen, CD4, and viral load testing methodologies in order to trim down their implementation complications and enhance portability and accessibility.
Sample copy of this report: https://www.crystalmarketresearch.com/report-sample/HC11320 .
HIV Diagnostics - Industry Trend Analysis
The global HIV diagnostics market was evaluated around USD 11.81 billion in the 2012 and is expected to reach approximately USD 30.24 billion by the end of 2022 while registering itself at a compound annual growth rate (CAGR) of 9.86% over the forecast period. Owing to the technological advancements of disease diagnostic tests, and the expected commercialization and development of innovative, authorities sanctioned POC and faster p24 antigen, EID, and CD4 tests. There is a rising need to establish easily available, proficient and accurate diagnostics tests. Owing to the financial resource-restricted settings in a major market share of the regions that are impacted by disease; it is still not possible to execute the complex, current screening, monitoring and staging tests. This is either owing to the deficiency of adequate testing labs or a need of skilled technicians competent of executing the tests. These restrictions of lab-based testing are an accelerator to the expansion of easy to implement and portable rapid, point of care tests. At present, a very few number of these tests are accessible in the market worldwide. Though, in the current scenario, a number of rapid or POC tests are under scientific progress and analysis. This anticipated augmenting in a number of product benefits to the global market which is estimated to drive the global HIV diagnostics market growth further during the forecast years.
HIV Diagnostics - The global HIV diagnostics market is segmented as follows –
HIV Diagnostics - By Product: Antibody Tests, HIV-1 Screening Tests, ELISA/EIA, Home Access Dried Blood Spot, Rapid Tests (Dot plot, HIV-1 Antibody Confirmatory Tests, Western Blot Test, Indirect Immunofluorescent Antibody Assay (IFA), Line Immunoassay, RadioImmunoPrecipitation Assay (RIPA), HIV-2 & Group O Diagnostic Tests, Blood Antibody Tests, Dried Blood Spot (DBS) Test, Viral Identification Assays, P24 Antigen Test, Qualitative PCR Tests, Viral Culture, CD4 Testing, Viral Load Testing, Early Infant Diagnostics
HIV Diagnostics - Product Outlook and Trend Analysis
The HIV diagnostics market embraces diagnostic confirmatory and screening tests for HIV-1, 2 and group O occurrence testing. These tests have chief applications to monitor and distinguish between the variety of subtypes and groups of human immunodeficiency virus (HIV). At a wider level, diagnostic products and tests can be segmented into viral identification assays, antibody tests, viral load testing, early infant diagnosis (EID), and CD4 testing. EID is carried out independently than CD4 testing and viral load testing due to the existence of antibodies by maternal blood within infants under the age group of 18 months, outcomes from the abovementioned tests turn out to be incorrect. Hence, DNA PCR molecular test is utilized for infant HIV screening and diagnostics, therefore warranting a different market section reporting for the same. The leading market share for the HIV diagnostics market in 2014 was reported by antibody tests. This major share can be mainly assigned to the existence of a large quantity of antibody tests in this market that can be further again parted into 1 confirmatory, HIV-1 screening, and 2 & Group O tests. These involve modern 4th and 3rd generation POC/NonPOC dried blood spot tests, ELISA tests, western blot, rapid agglutination for HIV-1 screening, radioimmuno-precipitation assay, and indirect immunofluorescent antibody assay, for line immunoassays and disease confirmation for disease. Other test section in the global market involve viral culture and p24 antigen tests for viral identification, CD4 testing, and viral load testing; p24 antigen tests are lesser sensitive as compared to antibody and are utilized in blend with them to render HIV testing functionality and complimentary screening. These tests are necessary for the monitoring and implementation of antiretroviral therapy; once affirmative verification of the contamination is prevailed. In the present market situation, these tests are complicated to use and require laboratories with skilled technicians. The anticipated technological innovations of these testing sections giving augment to the advent of new POC tests is also projected to drive the global HIV diagnostic tests market growth.
HIV Diagnostics - By Region:
North America - U.S, Canada, Mexico
Europe - Germany, France, UK, Italy, Spain, Rest of Europe
Asia-Pacific - Japan, China, Australia, India, South Korea, Rest of Asia Pacific
Rest of the World - Brazil, South Africa, Saudi Arabia, United Arab Emirates, Others
HIV Diagnostics - Regional Outlook and Trend Analysis
Global HIV diagnostics market can be classified into Europe, North America, Latin America, Asia-Pacific, and Middle East Asia. In 2014, North American regional HIV diagnostics market reported for the major share of global market revenue due to the existence of a technologically innovative medical framework, encouraging compensation policies and comparatively elevated healthcare spending in research and development. This region is anticipated to experience a rise in market demand further over the projected phase with the technological expansion of portable and rapid diagnostic tests. Though, the Asia-Pacific regional HIV diagnostics market, due to the existence of high unfulfilled demand in China and India, is projected to grow at a comparatively rapid rate during the forecast years.
HIV Diagnostics - List of Tables
Table 1.HIV Diagnostics Market, By Product ($Million), 2012-2022
Table 2.Antibody Tests Market, By Type ($Million), 2012-2022
Table 3.Antibody Tests Market, By Region ($Million), 2012-2022
Table 4.HIV-1 Screening Tests Market, By Type ($Million), 2012-2022
Table 5.HIV-1 Screening Tests Market, By Region ($Million), 2012-2022
Table 6.ELISA/EIA Market, By Region ($Million), 2012-2022
...
HIV Diagnostics - List of Figures
Figure 1.HIV Diagnostics Market, Share, By Product, 2016 & 2025
Figure 2HIV Diagnostics Market, By Region, 2016, ($Million)
Figure 3.Alere Inc.: Net Revenues, 2014-2016 ($Million)
Figure 4.Alere Inc.: Net Revenue Share, By Segment, 2016
Figure 5.Alere Inc.: Net Revenue Share, By Geography, 2016
Figure 6.Beckman Coulter: Net Revenues, 2014-2016 ($Million)
Figure7.Beckman Coulter: Net Revenue Share, By Segment, 2016
...
Get more information of this report: https://www.crystalmarketresearch.com/report/hiv-diagnostics-market .
Reason to Buy -
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the HIV Diagnostics market, thereby allowing players to develop effective long term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
Continued…
About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customised research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: [email protected]